-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7

Benzinga·11/14/2025 17:41:48
Listen to the news
Roth Capital analyst Sean McGowan maintains Synergy CHC (NASDAQ:SNYR) with a Buy and lowers the price target from $10 to $7.